Disruption of a topoisomerase-DNA cleavage complex by a DNA helicase.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 7991579.
- Also identified by PMC identifier 45370.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The type II DNA topoisomerases are targets for a variety of chemotherapeutic agents, including the antibacterial quinolones and several families of antitumor drugs. These agents stabilize an enzyme-DNA cleavage complex that consists of the topoisomerase covalently linked to the 5' phosphates of a double-stranded DNA break. Although the drug-stabilized cleavage complex is readily reversible, it can result in cell death by a mechanism that remains uncertain. Here we demonstrate that the action of a DNA helicase can convert the cleavage complex into a nonreversible DNA break by displacing DNA strands from the complex. Formation of a nonreversible DNA break, induced by a DNA helicase, could explain the cytotoxicity of these topoisomerase poisons.
Medical subject headings
- Adenosine Triphosphatases
- DNA Helicases
- DNA Topoisomerases, Type II
- Plasmids